{
    "2019-10-11": [
        [
            {
                "time": "",
                "original_text": "选择此时与股东“撕破脸”：贝达药业究竟剑指何方？",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "股东",
                        "撕破脸",
                        "减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业支柱单品在带量采购中竞标失败 遭股东清仓减持 减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "带量采购",
                        "竞标失败",
                        "清仓减持"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}